The collaboration will leverage Abalone Bio’s Functional Antibody Selection Technology platform for an undisclosed ...

One day, probably in the next year or two, a company will claim it has put the first artificial-intelligence-designed ...

DoP may exempt 11 more drugs from public procurement rules that restricts global tender: Gireesh Babu, New Delhi Tuesday, January 13, 2026, 08:00 Hrs [IST] The Department of Pharm ...

VYVGART was well-tolerated with a safety profile consistent with the established profile of VYVGART in patients with AChR-Ab seropositive gMG and other indications. No new safety concerns were ...

Explore the transformative potential of bispecific antibodies in multiple myeloma, offering hope for improved patient ...

A new multi-pronged antibody design could help immune cells receive stronger activation signals against cancer. Researchers ...

FDA Breakthrough designation supports development of a point-of-care test for detecting folate receptor autoantibodies ...

SOUTH SAN FRANCISCO, Calif., January 12, 2026--insitro, the AI therapeutics company built on causal biology, today announced the acquisition of CombinAbleAI and the launch of insitro’s TherML™ ...

Researchers at the University of Southampton have developed a promising new way to bolster the body's immune system response to cancer.

As we head into the 2026, let's take a look at biotech licensing deals and M&As that were inked in December 2025.

Mature biopharma deals are stealing all the headlines, but Bristol Myers Squibb’s Robert Plenge says the company’s deals with ...

Long COVID affects an estimated 65 million people worldwide and can damage the brain, heart, blood vessels, and immune system ...